Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (351-360 of 394) with videos related to

Pageof 40
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2017
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapyJose D Debes, Aaron J Chan, Domingo Balderramo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2007
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral populationApinya Leerapun, Sri V Suravarapu, John P Bida, et al.
Cardiovascular and Interventional Radiology|October 25, 2012
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinomaLaura E Moreno-Luna, Ju Dong Yang, William Sanchez, et al.
Investigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Cancer Letters|May 25, 2016
Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion proteinYu Wang, Xiwei Ding, Shaoqing Wang, et al.
Cancers|May 14, 2022
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and CholangiocarcinomaKatsuyuki Miyabe, Vinay Chandrasekhara, Nicha Wongjarupong, et al.
Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.
Hepatology Communications|December 11, 2020
Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina FasoNicha Wongjarupong, Albert Theophane Yonli, Bolni Marius Nagalo, et al.
Gastroenterology|March 18, 2019
Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in MiceKhaled Aziz, Jazeel F Limzerwala, Ines Sturmlechner, et al.
Human Mutation|July 12, 2016
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular CarcinomaPatrick R Blackburn, Raymond D Hickey, Rebecca A Nace, et al.
Pageof 40

Showing results (351-360 of 394) with videos related to

Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2017
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapyJose D Debes, Aaron J Chan, Domingo Balderramo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2007
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral populationApinya Leerapun, Sri V Suravarapu, John P Bida, et al.
Cardiovascular and Interventional Radiology|October 25, 2012
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinomaLaura E Moreno-Luna, Ju Dong Yang, William Sanchez, et al.
Investigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Cancer Letters|May 25, 2016
Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion proteinYu Wang, Xiwei Ding, Shaoqing Wang, et al.
Cancers|May 14, 2022
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and CholangiocarcinomaKatsuyuki Miyabe, Vinay Chandrasekhara, Nicha Wongjarupong, et al.
Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.
Hepatology Communications|December 11, 2020
Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina FasoNicha Wongjarupong, Albert Theophane Yonli, Bolni Marius Nagalo, et al.
Gastroenterology|March 18, 2019
Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in MiceKhaled Aziz, Jazeel F Limzerwala, Ines Sturmlechner, et al.
Human Mutation|July 12, 2016
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular CarcinomaPatrick R Blackburn, Raymond D Hickey, Rebecca A Nace, et al.
Pageof 40